simvastatin has been researched along with Anasarca in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kourounakis, AP; Matralis, AN | 1 |
| Barbirato, DDS; Diniz, JA; do Nascimento, EHL; Dourado, ACAG; Laureano Filho, JR; Pontual, ADA | 1 |
| Aghajanzadeh, M; Andalib, S; Danafar, H; Shirinzadeh, A; Zamani, M | 1 |
| Huang, CJ; Kao, MC; Li, KY; Shih, PC; Tsai, PS; Yang, CH | 1 |
| Ding, HJ; Ong, SG | 1 |
| Basta-Jovanović, G; Chatterjee, PK; Nesic, Z; Prostran, M; Radojevic-Skodrić, S; Stojanović, R; Thiemermann, C; Todorovic, Z; Velicković, R | 1 |
| Dobrić, S; Jaćević, V; Milovanović, ZA; Nezić, L; Satara, SS; Skrbić, R; Stojaković, N; Stojiljković, MP | 1 |
| Bersani-Amado, CA; Bracht, L; Caparroz-Assef, SM; Cuman, RK; Magon, TF; Ritter, AM | 1 |
| Boyd, AR; Hinojosa, CA; Orihuela, CJ; Rodriguez, PJ | 1 |
| Cheng, YT; Gao, RL; Geng, YJ; Li, XD; Yang, YJ; Yuan, JQ; Zhang, HT; Zhao, JL | 1 |
| Barbier, O; Blanquart, C; Briand, O; Dombrowicz, D; Duhem, C; Fruchart, JC; Glineur, C; Paumelle, R; Percevault, F; Staels, B; Woerly, G | 1 |
| Cakmak, A; Demirpençe, E; Deniz Dinçer, U; Köksoy, A; Köksoy, C; Okcu-Heper, A; Oziş, E; Yazgan, U | 1 |
1 trial(s) available for simvastatin and Anasarca
| Article | Year |
|---|---|
Tomographic evaluation of the effect of simvastatin topical use on alveolar bone microarchitecture, pain and swelling after mandibular third molar extraction: a randomized controlled trial.
Topics: Alveolar Bone Loss; Alveolar Ridge Augmentation; Edema; Humans; Molar, Third; Pain; Simvastatin; Single-Blind Method; Tooth Extraction; Tooth Socket | 2022 |
11 other study(ies) available for simvastatin and Anasarca
| Article | Year |
|---|---|
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Biphenyl Compounds; Carrageenan; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Diet, High-Fat; Drug Design; Edema; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hypolipidemic Agents; In Vitro Techniques; Indicators and Reagents; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Male; Mice; Microsomes; Phenothiazines; Picrates; Rats | 2014 |
In vivo study of mPEG-PCL as a nanocarriers for anti-inflammatory drug delivery of simvastatin.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Drug Carriers; Drug Delivery Systems; Edema; Male; Micelles; Polyesters; Polyethylene Glycols; Rats, Wistar; Simvastatin | 2019 |
Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Brain; Brain Diseases; Chemokine CXCL2; Claudin-3; Claudin-5; Drug Evaluation, Preclinical; Edema; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Sepsis; Simvastatin; Survival Rate | 2015 |
Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR.
Topics: Aged; Autoantibodies; Azathioprine; Biopsy; Bulbar Palsy, Progressive; Edema; Glucocorticoids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Recovery of Function; Simvastatin; Treatment Outcome | 2017 |
Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.
Topics: Animals; Creatinine; Disease Models, Animal; Drug Administration Schedule; Edema; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Kidney; Kidney Tubular Necrosis, Acute; Male; Rats; Rats, Wistar; Reperfusion Injury; Simvastatin; Sodium; Time Factors | 2008 |
Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Indomethacin; Inflammation; Male; Neutrophil Infiltration; Rats; Rats, Wistar; Simvastatin | 2009 |
Topical anti-inflammatory effect of hypocholesterolaemic drugs.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Croton Oil; Ear; Edema; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Neutrophil Infiltration; Neutrophils; Peroxidase; Simvastatin; Skin | 2011 |
Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia.
Topics: Acute Lung Injury; Administration, Oral; Animals; Anticholesteremic Agents; Cytokines; Disease Models, Animal; Edema; Female; Histocytochemistry; Lung; Mice; Mice, Inbred BALB C; Pneumonia, Pneumococcal; Simvastatin; Streptococcus pneumoniae; Survival Analysis | 2012 |
The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.
Topics: Animals; Aquaporins; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Edema; Myocardial Reperfusion Injury; Signal Transduction; Simvastatin; Swine; Swine, Miniature | 2013 |
Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway.
Topics: Animals; Edema; Extremities; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR alpha; Protein Kinase C; Signal Transduction; Simvastatin | 2006 |
Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model.
Topics: Animals; Diabetes Mellitus, Experimental; Edema; Glutathione; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Malondialdehyde; Muscle, Skeletal; Necrosis; Peroxidase; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Severity of Illness Index; Simvastatin; Time Factors; Tourniquets | 2007 |